ORGS Stock UPDATES Orgenesis Inc (ORGS) 0.5300 08/02/2014 22

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orgenesis Inc (ORGS) 0.5300 $ORGS

Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
Marketwire - Mon Jul 07, 7:40AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian subsidiary, Orgenesis SPRL, has signed a strategic agreement with MaSTherCell SA of Gosselies, Belgium. Orgenesis believes that the agreement will enable Orgenesis to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II clinical trials.

Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
Marketwire - Wed Jun 25, 7:31AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5 million via a senior secured term loan facility.

Orgenesis Awarded Maryland Stem Cell Research Fund Grant
Marketwire - Thu May 29, 1:18PM CDT
Orgenesis Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its' wholly owned subsidiary in Maryland, Orgenesis Maryland, Inc., has been awarded a grant of $420,000 from the Maryland Stem Cell Research Fund (MSCRF). The grant will assist Orgenesis as the company finalizes pre-clinical work in preparation for Phase I and Phase II clinical trials in the United States. The company is located in Germantown, Maryland.

Orgenesis Secures $3 Million in Funding From Kodiak Capital Group
Marketwire - Wed Dec 18, 10:02AM CST
Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver cells into functioning insulin-producing cells, has entered into a $3 million common stock purchase agreement with Kodiak Capital Group LLC, a Newport Beach, Calif.-based institutional investor.

Orgenesis to Present at the 2013 Gateway Conference on September 10
Marketwire - Wed Sep 04, 4:16PM CDT
Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, has been invited to present at the 2013 Gateway Conference being held on Tuesday, September 10, 2013 at the Palace Hotel in San Francisco.

Dr. David Sidransky Appointed to Orgenesis' Board of Directors
GlobeNewswire - Thu Jul 18, 1:00PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Dr. David Sidransky, Professor and Director of the Head and Neck Cancer Research Division at the Johns Hopkins University School of Medicine's Department of Otolaryngology, to its Board of Directors.

Orgenesis to Present Updates at Two Key June Conferences
GlobeNewswire - Thu May 30, 1:30PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that it will be presenting updates on the Company's business and technology at two key conferences in the month of June.

Orgenesis and ATMI Enter Into Process Development Agreement
GlobeNewswire - Thu May 09, 6:55AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its wholly owned subsidiary, Orgenesis Ltd., has entered into a process development agreement (the "PD Agreement" with ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions.

Leading Diabetes Expert, Jay S. Skyler, M.D., Joins Orgenesis' Scientific Advisory Board
GlobeNewswire - Thu Apr 11, 7:15AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Jay S. Skyler, M.D., to its Scientific Advisory Board.

Orgenesis to Present at ATTD 2013
GlobeNewswire - Wed Feb 20, 1:11PM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that its Chief Science Officer, Prof. Sarah Ferber, is scheduled to present at the 6 International Conference on Advanced Technologies & Treatments for Diabetes, to be held February 27 - March 3, 2013 in Paris, France.

Orgenesis Announces Management Changes
GlobeNewswire - Mon Jan 07, 7:00AM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today the appointment of Sav DiPasquale as President and Chief Executive Officer. Mr. DiPasquale succeeds Jacob BenArie, who has been appointed Chief Executive Officer of the Company's private subsidiary, Orgenesis Ltd.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Howmet Aerospace Stock Faces Downgrade Amid Demand Concerns

Updated Category News Views 127

Understanding KeyBanc's Downgrade of Howmet Aerospace Howmet Aerospace Inc. (NYSE:HWM) recently saw a shift in its stock evaluation when KeyBanc moved its rating from Overweight to Sector Weight. This decision comes in response to a noticeable cooling in demand within the commercial aerospace industry, prompting analysts to reconsider their outlook on the company. Despite...

Continue Reading
Franklin Templeton Launches Innovative ETFs for Investors

Updated Category News Views 157

Franklin Templeton Introduces New ETF Offerings Franklin Templeton recently announced the launch of two exciting new ETFs aimed at returning enhanced dividend income. These innovative investment products are the Franklin U.S. Dividend Multiplier ETF (XUDV) and the Franklin International Dividend Multiplier ETF (XIDV). Developed in collaboration with New Frontier and...

Continue Reading
Insights into the Emerging Commercial Vehicle Market Trends

Updated Category News Views 166

Signs of Recovery in the Commercial Vehicle Market The commercial vehicle market is experiencing a notable recovery. According to the latest analysis from Work Truck Solutions, new commercial vehicle sales are revitalizing the industry, leading to advantageous effects in the used vehicle sector. As inventory levels stabilize, the ecosystem is transitioning into a phase...

Continue Reading
Expansion of COOL-BINZ Franchise Across Four New Markets

Updated Category News Views 176

BELFOR Franchise Group Expands COOL-BINZ Franchise Locations BELFOR Franchise Group, known for its excellent residential and commercial services, has made significant advancements with the COOL-BINZ franchise. The company celebrates the onboarding of new franchise owners, successfully extending its reach into four different markets. Welcoming New Franchise Owners The...

Continue Reading
Exploring Growth in the Global Bread Crumbs Market Trends

Updated Category News Views 348

A Look into the Bread Crumbs Market and Its Future Growth The global bread crumbs market is poised for remarkable growth, with projections indicating an increase from USD 1.13 billion to USD 2.16 billion over the coming years. This growth represents a compound annual growth rate (CAGR) of 6.7%. The driving forces behind this robust expansion are evolving consumer...

Continue Reading